Part D/Prescription Drugs – Page 35 – medicarereport.org

Friday, September 11, 2026

Latest:

Health Care - General Part D/Prescription Drugs

Arlene Sharp April 5, 2024April 5, 2024 GLP-1, medicincal research, Parkinson’s Disease

Ozempic predecessor may slow Parkinson’s progression, new study shows

By Erica Carbajal for Becker’s Hospital Review on April 4, 2024 A small study has found lixisenatide, a GLP-1 made

Health Care - General Health Care Finance Health Insurance Part D/Prescription Drugs Price Transparency

Arlene Sharp April 5, 2024April 5, 2024 Healthcare Costs, Insulin, medicare, Medicare Part D, Older Adults

Biden Is Right About $35 Insulin Cap but Exaggerates Prior Costs for Medicare Enrollees

By Samantha Putterman, Politifact for KFF Health News on April 5, 2024 The cost of insulin in the United States

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook April 4, 2024April 4, 2024 CMS, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Advantage Benchmark, Medicare Advantage Utilization, Medicare FFS cost trends, Medicare Part D

Why higher Medicare Advantage utilization wasn’t reflected in 2025 rates

(By Jakob Emerson for Becker’s Hospital Review ) CMS has finalized a slight decrease in Medicare Advantage benchmark payments for

CMS Health Care Finance Medicare Advantage Part D/Prescription Drugs

Eileen Cook April 2, 2024April 2, 2024 CMS, Healthcare Finance, Medicare Advantage, Medicare Advantage Benchmark, Medicare Part D

CMS finalizes 2025 Medicare Advantage rates

(By Rylee Wilson for Becker’s Hospital Review ) CMS finalized a slight decrease in Medicare Advantage benchmark payments for 2025.

CMS Health Care Finance HHS Legal Actions/Court Decisions Medicare Advantage Part D/Prescription Drugs

Eileen Cook March 28, 2024March 28, 2024 CMS, Healthcare Finance, HHS, Lawsuit, Medicare Advantage, Medicare Advantage Star Ratings, Medicare Part D

CMS faces another challenge of Medicare Advantage star ratings methodology

(By Rylee Wilson for Becker’s Hospital Review ) A Medicare Advantage insurer facing termination of one of its contracts from

CMS Health Care Finance Medicare - General Part D/Prescription Drugs

Eileen Cook March 25, 2024March 25, 2024 CMS, Drugs for Weight Loss, GLP-1s drugs, Healthcare Costs, Healthcare Finance, medicare, Medicare Part D, Ozempic

Gross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing – Even Though Medicare Cannot Cover The Drugs for Weight Loss

(By Chris Lee for The Kaiser Family Foundation published March 23, 2024) A KFF analysis shows that gross total Medicare

Part D/Prescription Drugs

Eileen Cook March 21, 2024March 21, 2024 Dept of Defense, High-risk Medication, Medicare Part D, pharmaceuticals, Trade Agreements Act

54% of meds at ‘high risk,’ military says

(By Paige Twenter for Becker’s Hospital Review ) More than half of pharmaceuticals in the United States have a dependency

Aging CMS Dental/Oral Health DME Health Care - General Health Care Finance Medicare - General Medicare Advantage Medigap Part D/Prescription Drugs

Eileen Cook March 18, 2024March 18, 2024 Dental, Healthcare Costs, Hearing Aids, medicare, Medicare Advantage, Medicare Advantage Vision care, Medicare Part D, Medigap, Out-of-pocket costs

Medicare Households Spend More on Health Care Than Other Households

(By Nancy Ochieng, Juliette Cubanski, and Anthony Damico for The Kaiser Family Foundation Published: Mar 14, 2024) Medicare provides health

Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook March 12, 2024March 12, 2024 medicare, Medicare Advantage, Older Adults, SNP

Enrollment in Medicare Advantage

A recent report shows Medicare Advantage enrollment has increased by almost 2 million beneficiaries in 2023. Currently, 33 million individuals

Health Care Redesign Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook March 11, 2024March 11, 2024 CMS, medicare, Medicare Advantage, Medicare Part D, Older Adults, Prior Authorization

Part D plans ramp up prior authorization

(By Rylee Wilson for Becker’s Hospital Review ) Medicare Part D plans have ramped up restrictions on prescription drugs since